Health Canada inspection
Acerus Pharmaceuticals Corporation: Health Canada inspection of Feb 18, 2026
Health Canada · GMP · rating I
Key facts
| Establishment | Acerus Pharmaceuticals Corporation |
|---|---|
| City | Toronto |
| Province | Ontario |
| Country | Canada |
| Program | GMP |
| Start date | Feb 17, 2026 |
| End date | Feb 18, 2026 |
| Rating | I |
| Rating description | Inspection in progress |
| Licence number | 102281 |
At a glance
- 1–9 Inspections of this establishment
- Yes Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.